Mithra Pharmaceuticals SA
MITPF News Today: Stay Updated with the Latest Mithra Pharmaceuticals SA News in Real Time
Find MITPF news now at Meyka AI. Stay informed with the latest Mithra Pharmaceuticals SA stocks updates, including price news, market analysis, and expert insights.
MIRM Mirum Pharmaceuticals, Inc. Feb 26 2026 Leerink Maintains Outperform
MIRM analyst rating update: three firms maintained Outperform on Feb 26, 2026; Leerink cut PT to $118
BAYN.DE Bayer AG (XETRA) pre-market: earnings due 04 Mar 2026, guidance key
Pre-market BAYN.DE stock preview ahead of 04 Mar 2026 earnings; key metrics, Meyka AI forecast and price targets
PHASQ (PhaseBio Pharmaceuticals, PNK) down 99% on 26 Feb 2026: key risks ahead
PHASQ stock falls 99% on 26 Feb 2026; analysis, Meyka grade and model forecast for PhaseBio on PNK
BofA Maintains Neutral on Recursion Pharmaceuticals (RXRX) Feb 25, 2026
RXRX analyst rating: BofA maintained Neutral and cut PT to $6 on Feb 25, 2026, with implications for investors
Sanofi Consumer Healthcare Shares Jump 14% as Q4 Profit Surges 50%, ₹75 Dividend Announced
The Indian stock market witnessed a strong rally in Sanofi Consumer Healthcare Shares after the company reported impressive fourth quarter results. The stock surged 14% in a single session following a 50% rise in net profit and the announcement of a ₹75 dividend. This sharp movement attracted the attention of retail and institutional investors alike….
Australia stocks higher at close of trade; S&P/ASX 200 Gains 0.51%
Australia’s equity market finished Thursday on a positive note, with the benchmark S&P/ASX 200 Index rising 0.51% by the close. Investor sentiment was lifted by strong corporate earnings and favorable global cues, pushing the index closer to record levels. Broad-based gains were observed across key sectors, particularly technology, healthcare, and mining, while select travel and…
Needham Maintains Buy on Ionis Pharmaceuticals (IONS) Feb 25, 2026
IONS analyst rating update: Needham maintains Buy and raises PT to $103; RBC reiterates Outperform on Feb 25, 2026
Up 25.6% pre-market 26 Feb 2026: 4582.T SymBio (JPX) high-volume move
Pre-market high-volume move in 4582.T stock: price JPY 201.00 on 26 Feb 2026 with volume 61,405,100 shares
H.C. Wainwright Maintains Buy on ORIC (ORIC Pharmaceuticals, Inc.) Feb 2026
H.C. Wainwright maintained Buy and raised ORIC price target to $25 on Feb 24, 2026 — ORIC analyst rating update